Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000553909 | SCV000626816 | likely benign | Cowden syndrome | 2023-10-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001815400 | SCV002062522 | likely benign | not provided | 2021-10-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002448618 | SCV002736531 | likely benign | Inborn genetic diseases | 2022-02-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004541646 | SCV004783458 | likely benign | PIK3CA-related disorder | 2023-06-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |